Clinical Trial Update: Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study) [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/Phase 2 clinical trial evaluating vitamin C for sympathetic-vascular dysfunction in obesity and insulin resistance; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Hypertension

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Hypertension, Cardiovascular Diseases | Phase 1, Phase 2 | Status: RECRUITING